By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Research Digest > New Studies > World’s Largest Longevity Competition Targets Age Reversal Breakthroughs
New StudiesResearch Digest

World’s Largest Longevity Competition Targets Age Reversal Breakthroughs

GMJ
Last updated: 29/05/2026 17:24
By
GMJ Research Desk
Share
4 Min Read
Scientific researchers working on longevity interventions in laboratory setting
The XPRIZE Healthspan competition offers $101 million in prizes for age reversal breakthroughs targeting cognitive, muscle, and immune function. Dr. Jamie Justice leads scientific oversight of the world's largest longevity research initiative. — Photo: Mike van Schoonderwalt / Pexels
SHARE
🎧 Listen to this article3:54 min · 528 words · GMJ Audio
3 min read|528 words

The XPRIZE Healthspan competition, the world’s largest longevity research initiative, is driving unprecedented innovation in age reversal science. Dr. Jamie Justice, the competition’s scientific director and a researcher at Wake Forest University School of Medicine, oversees teams developing interventions to restore youthful function in older adults.

Contents
      • XPRIZE Healthspan Competition Structure
  • Competition Targets Three Core Functions
  • Promising Research Areas Emerge
  • Warning Against Unproven Treatments
    • Key takeaways
  • Frequently asked questions
    • What makes this longevity competition different from previous research efforts?
    • How long do teams have to develop their interventions?
    • What should consumers know about current longevity treatments?
$101 million
total prize funding for longevity research breakthroughs

XPRIZE Healthspan Competition Structure

Prize distribution across research categories, 2024-2030

Cognitive Function
$20M
Muscle Function
$20M
Immune Function
$20M
Milestone Prizes
$14M
Audacious Goal

$11M

Source: XPRIZE Foundation, 2024 | Georgian Medical Journal News

Competition Targets Three Core Functions

The XPRIZE Healthspan competition focuses on restoring three critical age-related declines: cognitive function, muscle strength, and immune system performance. Dr. Jamie Justice, who leads the scientific oversight, explained that teams must demonstrate measurable improvements in older adults within specific timeframes.

Submit Your Paper
GMJ_Submit_Banner

The competition structure includes milestone prizes for incremental breakthroughs and grand prizes for transformative results.

Promising Research Areas Emerge

Justice highlighted several research directions showing significant potential in early trials. Cellular reprogramming approaches and targeted interventions for metabolic dysfunction represent leading strategies among competing teams.

The competition has attracted researchers from major institutions worldwide, with teams exploring everything from pharmaceutical interventions to lifestyle modifications. Justice noted that the most promising approaches combine multiple modalities rather than relying on single interventions.

Warning Against Unproven Treatments

While emphasizing legitimate research progress, Justice warned against what she termed “purely scammy” longevity treatments flooding the market. The FDA has issued warnings about unregulated anti-aging products making unsupported claims.

Justice stressed that effective longevity interventions require rigorous clinical testing and regulatory approval. The XPRIZE competition specifically requires teams to demonstrate safety and efficacy through controlled trials meeting scientific standards.

Teams must demonstrate measurable restoration of function in cognitive performance, muscle strength, and immune response in adults aged 65-80 within the competition timeframe.

— Dr. Jamie Justice, Wake Forest University School of Medicine (XPRIZE Healthspan, 2024)

Key takeaways

  • The $101 million XPRIZE Healthspan represents the largest longevity research competition globally
  • Three target areas include cognitive function, muscle strength, and immune system performance
  • Dr. Justice warns against unregulated “anti-aging” products lacking scientific evidence
  • Promising approaches combine multiple interventions rather than single treatments

Frequently asked questions

What makes this longevity competition different from previous research efforts?

The XPRIZE Healthspan requires demonstrable restoration of youthful function in older adults, not just slowing decline. Teams must show measurable improvements in cognitive, muscle, and immune function within specific timeframes.

How long do teams have to develop their interventions?

The competition runs from 2024 to 2030, giving teams six years to develop and test their approaches. Milestone prizes are awarded for incremental progress, with grand prizes for transformative breakthroughs.

What should consumers know about current longevity treatments?

Dr. Justice warns against unregulated products making anti-aging claims without scientific evidence. Effective longevity interventions require rigorous clinical testing and regulatory approval before reaching consumers.

The XPRIZE Healthspan competition represents a watershed moment for longevity science, bringing unprecedented resources and scientific rigor to age reversal research. As teams advance through the competition phases, the results may fundamentally reshape our understanding of aging and therapeutic possibilities. The emphasis on measurable functional restoration, rather than biomarker changes alone, could accelerate the translation of laboratory findings into real-world treatments for age-related decline.

Source: STAT+: The woman behind the world’s biggest longevity competition

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Eye-tracking study reveals depression shifts children's attention to sad facesJul 14, 2026
Correction issued for MAGE-A4/A8 immunotherapy trial in advanced solid tumoursJul 14, 2026
Jackfruit-derived biomaterial shows promise in reversing severe gum disease damageJul 14, 2026
Scientists Reprogram Brain Immune Cells to Combat Alzheimer's DiseaseJul 14, 2026
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:age reversalaginghealthspanlongevity researchXPRIZE
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Guidance on Inadvertent Vaccination in Pregnancy: What Healthcare Providers Need to Know

UK health authorities have published guidance for healthcare professionals managing inadvertent live…

UK Charity Maggie’s to Open Two New Cancer Care Centres in Coventry and Birmingham

Charity Maggie's will open two new dedicated cancer care centres in Coventry…

Beyond the Breakthrough: Pancreatic Cancer Researchers Warn Real Work Is Just Beginning

A new STAT News commentary warns that while breakthrough pancreatic cancer drugs…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Scientific illustration showing polyphenol molecules binding to iron in digestive system
New StudiesResearch Digest

How Coffee and Tea Reduce Iron Absorption by Up to 94% Through Polyphenol Binding

By
GMJ Research Desk
27/05/2026
Scientific diagram showing increased driving impairment levels when cannabis edibles are combined with alcohol
New StudiesResearch Digest

Cannabis Edibles and Alcohol Create Hidden Impairment Risk for Drivers, Johns Hopkins Study Reveals

By
GMJ Research Desk
10/06/2026
Portrait of Dr. James Phillip Luby in laboratory setting with medical equipment
New StudiesResearch Digest

James Phillip Luby, Pioneer of Infectious Disease Research, Dies at 91

By
GMJ Research Desk
05/06/2026
Medical researchers discussing stroke trial methodology and neuroprotection challengesIllustrative image · Photo by Thirdman on Pexels (Pexels License)
Clinical UpdatesNew StudiesPracticeResearch Digest

Minocycline Stroke Trial Debate Highlights Neuroprotection Research Challenges

By
GMJ Practice Desk
05/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up